Heart health after immunotherapy for melanoma
Part of Cancer, Heart & circulation, Injuries & trauma, Skin clinical trials.
This study looks at heart health in people who have finished immunotherapy for melanoma. It uses MRI scans to check for any heart problems that may have developed after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with melanoma.
- Your melanoma was at stage IIB, IIC, III, or IV.
- You have finished immunotherapy (a type of cancer treatment that helps your immune system fight cancer) and are now on regular check-ups.
- It has been between 2 and over 10 years since you finished immunotherapy.
- You are 18 years or older.
- You do not have any metal implants (like some pacemakers or clips) that are not safe for MRI scans, and you are not claustrophobic or pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a simple blood test can track how well immunotherapy is working in people with advanced melanoma. It might help doctors see if the treatment is effective earlier than with scans alone.
This study watches heart health in people starting immunotherapy (a cancer treatment that boosts the immune system) by checking blood samples for heart-related markers. It aims to find early signs of heart problems so they can be managed sooner.
This study uses heart MRIs to monitor women with gynecologic cancers who are about to start immunotherapy. The goal is to detect early signs of heart problems so doctors can take action quickly.
This study looks at how to monitor and help patients who have had heart problems as a side effect of cancer immunotherapy. If you have recovered from such a heart issue, this program may support your heart health and overall recovery during and after cancer treatment.
This study tests whether giving aggressive cholesterol-lowering medication to people starting immunotherapy for melanoma can improve heart health. It may help reduce the risk of heart problems during cancer treatment.
This trial looks at whether immunotherapy drugs (checkpoint inhibitors) cause heart problems in people with certain cancers. It will help doctors understand who is at risk and how to monitor for side effects.
Hear when a new Melanoma Stage III or IV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.